Clinical Trial Update: Magnesium Sulfate to Prevent Hospitalisation of Acute Exacerbations of Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating magnesium sulfate to prevent hospitalization during acute exacerbations of chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Hôpital de Verdun | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: WITHDRAWN